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This paper reports the first direct demonstration of de novo synthesis of chondroitin sulphate proteo~ycans 
by Kurloff cells. This was achieved using highly purified splenic Kurloff cells labelled in vitro with [3sS]sul- 
phate and D-lJJ-3H]glucosamine. A single population of sulphated proteoglycans was observed after disso- 
ciative extraction, DEAE-cellulose chromatography, Sepharose CL 6B chromatography and fluorography 
after electrophoresis. These were large, highly anionic proteogly~ns and were completely digested by chon- 
droitinase AC or ABC. Moreover, glycosaminoglycan extracted from Kurloff cells had the electrophoretic 
mobility of control chondroitin sulphate. 
(Karloff cell, Spleen cell) ~akocyte Chondroitin surfate 
1. INTRODUCTION 
Kurloff cells (KC) [l] are found in the blood, 
spleen, thymus, lungs, liver, bone marrow and 
placenta of guinea pigs. They contain a large 
(11 pm diameter), periodic acid-Schiff positive in- 
clusion body (KB) which has long been 
histochemic~iy defined as a ‘mucoprotein- 
mucopoiysaccharide complex’ [2]. Under the eiec- 
tron microscope, the KB appears as a dense, 
homogeneous and amorphous central matrix sur- 
rounded by myeiinic figures and delineated by a 
single triiaminar membrane [3]. KC are more 
numerous in females than in males and increase 
considerably in number during pregnancy. 
Ledingham [4] showed that they were produced in 
both male and female guinea pigs after the ad- 
ministration of oestrogens. By extraction of KC- 
rich spleens (obtained from oestrogenized guinea 
* To whom reprint requests should be addressed 
pigs) a mucopoiysaccharide fraction was charac- 
terized as chondroitin suiphate (CS) [5] and then as 
CS proteogiycan (PG) [6]. Spleens obtained from 
oestrogenized guinea pigs were shown to have a 
higher glycosaminogiycan (GAG) content than 
control spleens and this finding was related [7] to 
the dramatic increase in spienic KC numbers in- 
duced by oestrogens. Moreover, very little incor- 
poration of [35S]suiphate into the spienic GAG was 
observed [7,8]. The intracellular localization of 
radiolabelied suiphate in the KB was demonstrated 
by autohistoradiography in guinea pigs given this 
isotope [2,9, lo]. PG analogous to Kurioff PG were 
extracted from the spleen of pregnant sheep, pigs, 
rats and humans [I I]. As these species were devoid 
of KC, they may have a specialized line of iym- 
phoid cells which are not histologically distin- 
guishable, as KC in guinea pigs, but contain 
similar PG and have a similar function. The ex- 
traction of a ubiquitous extra- or intracellular PG 
(possibly dependent on plasma oestrogen levels) 
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could not be excluded. The presence of CS-PG in 
the KB was very probable but the de novo synthesis 
of these PG by the KC itself has not yet been 
directly demonstrated [ 1, lo]. 
In this study, GAG were extracted from 95% 
purified and viable splenic KC and characterized 
by electrophoresis, as a KC purification technique 
has been available since 1984 [12]. These purified 
KC were also incubated with radiolabelled 
sulphate or glucosamine and Kurloff CS-PG were 
then extracted and characterized. 
2. MATERIALS AND METHODS 
2.1. Guinea pig oestrogenization and KC 
purification 
Oestrogenization of guinea pigs and KC 
purification were performed as previously de- 
scribed [ 121. 
2.2. Extraction and electrophoresis of Kurioff 
GAG 
KC or total spleens were homogenized in cold 
acetone; after centrifugation and drying, the 
pellets were digested, in turn, with pronase 
(1 mg/ml of 0.1 M Tris-HCl buffer, pH 7.5, 
0.005 M CaC12) for 48 h at 5O”C, ribonuclease and 
deoxyribonuclease (2 mg/ml of 0.005 M Tris-HCl 
buffer, pH 7.0,0.012 M MgS04) for 20 h at 30°C. 
GAG were isolated and purified by repeated 
cetylpyridinium chloride and ethanol precipita- 
tions [13]. 
Electrophoresis of GAG on a cellulose acetate 
membrane was performed in 0.05 M LiCl, pH 2.0 
[14]. The strips were transferred, without drying, 
to a 1% alcian blue solution in 2% acetic acid for 
30 min. CS and hyaluronic acid were used as a 
control. 
2.3. Uranic acid and protein determination 
Uranic acid and protein were determined ac- 
cording to Bitter and Muir 1151 and Lowry et al. 
[ 161, respectively. 
2.4. Metabolic labelling of KC and extraction of 
PG 
Incubation media were buffered with 1% of 1 M 
Hepes at pH 7.2 supplemented with antibiotics 
(penicillin, 200 IU/ml; streptomycin, 100 pg/ml; 
fungizone, 0.25 pg/ml) and 10% Ultroser HY 
300 
(IBF). After 30 min prestarving, 200-300 x 106, 
95% pure and 95% viable KC were incubated with 
either 300 &i [35S]sulphate (Amersham, spec. act. 
25-40 Ci/mg) for 12-18 h in 5 ml Fischer medium 
[17] or 20 &i D-[l-3H]glucosamine (CEA, spec. 
act. lo- 15 Ci/mM) for the same time in a glucose- 
free, Dulbecco phosphate buffered saline [18] sup- 
plemented with minimum Eagle medium [ 191, 
amino acid and vitamin solutions. 
After incubation, KC were washed three times in 
Hank’s balanced salt solution by successive spinn- 
ing and resuspension. The last pellet was 
resuspended in 4 ml extraction buffer: 4 M 
guanidinium chloride, 0.05 M Tris-HCl, pH 6.8, 
containing 10 mM EDTA, 100 mM 6-aminohex- 
anoic acid, 5 mM benzaminidium chloride, 10 mM 
ethylmaleimide, 0.36 mM pepstatin and 1 mM 
phenylmethanesulphone fluoride as protease in- 
hibitors [20]. The suspension was stirred at 4°C for 
20 h and centrifuged at 100000 x g for 60 min at 
4°C. 
2.5, Separation of glycoconjugates 
2.5.1. DEAE-cellulose chromatography 
The D-( 1-3H)- or 35S-labelled supernatants were 
dialysed against two 400 ml batches of 7 M urea 
containing the cocktail of protease inhibitors. 2 ml 
of the urea soluble, dialysed sample was then ap- 
plied to a DEAE-cellulose column (1.1 x 5 cm) 
equilibrated with 7 M urea in 0.05 M Tris-HCl 
buffer, pH 6.8, containing protease inhibitors. The 
column was eluted with the equilibration buffer 
(8 ml) and then with a 43 ml linear gradient of 
NaCl (O-l.2 M) at a flow rate of 25 ml/h. 1 ml 
fractions were collected and the radioactivity 
determined of 0.1 ml aliquots. 
2.5.2. Sepharose column chromatography 
The sulphated peak from DEAE-cellulose 
chromatography was dialysed extensively against 
distilled water. The non-diffusible material was 
freeze-dried, dissolved in 0.5 ml extraction buffer, 
layered on a Sepharose CL 6B column (0.7 x 
42 cm) and eluted with the same dissociative buffer 
(flow rate, 3 ml/h). 0.2 ml fractions were collected 
and radioactivity was assayed. 
2.6. Digestion with chondroitinases 
The radiosulphated peak obtained after suc- 
cessive DEAE-cellulose and Sepharose CL 6B 
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chromatography was dialysed extensively against 
water and freeze-dried. Hydrolysis was performed 
with 0.2 IU chondroitinase ABC or AC (Sigma) in 
0.05 M Tris/acetate buffer (pH 8.0) containing 
0.05 M NaCl for 18 h at 37°C. After digestion, 
solid guanidinium chloride was added to the sam- 
ple to give a final concentration of 4 M for 
Sepharose CL 6B chromatography. 
Alternatively, aliquots of the sulphated peak ob- 
tained from DEAE-cellulose were directly sub- 
jected to chondroitinase treatment under the same 
conditions. Homologous digested and undigested 
samples were mixed with Laemmli’s sample buffer 
for electrophoresis. 
2.7. Electrophoresis of PG and fluorography 
PAGE-lo% SDS was performed according to 
Laemmli [21]. Fluorography 1221 with Enlightning 
(NEN) was performed before exposure at -70°C 
for 30 days to Kodak X-Omat AR films. 
3. RESULTS 
3.1. Extraction of GAG from purified KC and 
from whole spleen 
The GAG concentration, expressed in pg uranic 
acid/mg protein, was 4.87 in purified KC whereas 
it was only 1.75 in splenic extracts. These results 
suggest hat a major part of the splenic GAG was 
located in KC. After electrophoresis of the GAG 
obtained from KC, only one alcian blue band was 
coloured on cellulose acetate. Its electrophoretic 
mobility was the same as control CS. No material 
was found with the electrophoretic mobility of 
hyaluronic acid. 
3.2. Separation of K&off PG by DEAE- 
cellulose 
Radiosulphated cellular extracts, corresponding 
to 150 x lo6 KC, were chromatographed on 
DEAE-cellulose. Fig.1 shows a single peak of 
sulphated material that eluted at an NaCl concen- 
tration of 0.55 M. The peak fractions were pooled 
and the resulting sample was dialysed against 
distilled water containing protease inhibitors and 
further analyzed as described below (sections 
3.3-3.5). 
After incubation with D-[ 1 -3H]glucosamine, 
similar radiolabeled KC extracts were chromato- 
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Fig. 1. DEAE 52-cellulose chromatography of urea- 
soluble KC extracts after incubation with radiolabelled 
sulphate. 4 M guanidinium chloride-soluble cellular 
extracts corresponding to 150 x lo6 KCs were dialysed 
against 7 M urea. The urea-soluble fraction was applied 
to a DEAE-cellulose column (1.1 x 5 cm) previously 
equilibrated with 7 M urea in 0.05 M Tris-HCl buffer 
(pH 6.8). Elution was performed with a O-l.2 M NaCl 
linear gradient (---). The flow rate was 25 ml/h and 
1 ml fractions were collected. The elution profile (-) 
was obtained with 0.1 ml aliquots. [35S]Sulphated 
fractions (26-34) (thin bar) were pooled, dialysed and 
freeze-dried for further studies. 
graphed under the same conditions on DEAE- 
cellulose (fig.2). Two peaks were eluted with the 
NaCl-free buffer. They contained almost all the 
protein of the sample and corresponded to 
glycoproteins [23], as demonstrated by PAGE- 
SDS followed by PAS staining (not shown). Three 
other peaks were eluted with NaCl concentrations 
of 0.18 M, 0.40 M and 0.55 M. The latter peak 
was eluted at exactly the same NaCl concentration 
as the single radiosulphated peak (fig.1). 
3.3. Gel filtration of the radiosulphated DEAE- 
cellulose peak on Sepharose CL 6B 
After Sepharose CL 6B filtration under 
dissociative conditions (fig.3), a single peak was 
eluted near the void volume (J& = 0.05). 
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Fig.2. DEAE 52-cellulose chromatography of urea- 
soluble KC extracts after incubation with radiolabelled 
glucosamine. KC were incubated with D-[l-3H]glucosa- 
mine. Chromatography was performed as described in 
fig.1. The last peak, eluted with 0.55 M NaCl, 
corresponds with the sulphated peak of fig.1. 
3.4. Effect of chondroitinases on the 
hydrodynamic size of the radiosulphated PG 
Aliquots of “S-1abelled glycoconjugates eluting 
first at 0.55 M NaCl on DEAE-cellulose and then 
at K=” = 0.05 on Sepharose CL 6B, were submitted 
to chondroitinase ABC or AC digestion and fur- 
ther gel filtration on the same Sepharose CL 6B 
column. The peak completely disappeared with 
both chondroitinase AC (fig.3) and chondroitinase 
ABC (not shown), and this was correlated with the 
appearance, near the total volume (I& = 0.96), of 
a single peak of lower molecular mass, sulphated 
December 1986 
.____ _____.._ __.__. _ .___._ _ ______--_’ 
I 
30 50 70 90 -110 
Fraction no 
Fig.3. Effect of chondroitinase AC on the Sepharose CL 
6B elution profile of the radiosulphated DEAE-cellulose 
peak illustrated in fig.1. The freeze-dried, sulphated 
sample was dissolved in 0.5 ml extraction buffer 
containing 4 M guanidinium chloride and applied to a 
column (0.7 x 42 cm) previously equilibrated with the 
same dissociative buffer. Material was eluted at a flow 
rate of 3 ml/h and 0.2 ml fractions were collected. The 
elution profile, indicated by (-), was obtained with 
0.1 ml aliquots. After counting, the remaining material 
of the single peak at Kav = 0.05 was pooled (thin bar) 
and submitted to chondroitinase AC digestion for 18 h 
at 37°C. The elution profile indicated by (---) was 
obtained by rechromatography of the digested material 
under the same conditions. Radioactivity was 
determined on the whole fractions. The K,, = 0.05 peak 
was completely digested and the degradation products 
(oligosaccharides) appeared as a Kav = 0.96 peak. The 
arrows indicate the void volume (VO) and the total 
volume (VJ of the column. 
degradation products. Almost all the radioactivity 
contained in the PG was recovered in the oligosac- 
charides. 
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3.5. Electrophoretic pattern of the radiosulphated fluorographic pattern (fig.4b) and stains all blue 
PG before and after chondroitinase staining pattern (not shown) of the sulphated 
digestion Kurloff PG. 
Fluorograms showed that almost all the CS-PG 
obtained from DEAE-cellulose chromatography 
was at the top of the stacking gels, and another 
band was observed at the top of the resolving gel 
(fig.4a,c). A similar blue pattern (not shown) was 
obtained with ‘stains all’ dye (BioRad) which 
specifically stains sulphated PG blue [24]. After 
chondroitinase AC (or ABC) treatment, there was 
a complete disappearance of the characteristic 
4. DISCUSSION 
The de novo synthesis of the CS-PG present in 
the KB by the KC themselves was therefore 
established for the first time. This finding rein- 
forces the hypothesis of the in situ formation of 
the KB and excludes an endocytic origin. The 
results presented here indicate that the only 
sulphated PG synthesized by KC is chondroitin 
sulphate. Further analysis is being carried out in 
our laboratory to characterize this more precisely, 
though published data [5,6] lead us to conclude 
that the sulphated KC-PG is probably chon- 
droitin4-sulphate. This inventory of KC-PG 
should not be regarded as complete. Non- 
sulphated PG have not yet been examined. The 
elution of the sulphated Kurloff PG with 0.55 M 
NaCl corresponds to a highly anionic PG such as 
CS-PG. Nevertheless our best criterion for its iden- 
tification is the high specificity of chondroitinase 
AC [25]. The K,, = 0.05 observed for the sulphated 
Kurloff PG is in agreement with its low penetra- 
tion in acrylamide gels. The significance of the 
presence of CS-PG in other leukocytes and, a for- 
tiori, in the enigmatic KC is uncertain. As in- 
tracellular (and particularly intralysosomal) 
CS-PG are involved in natural killer cytotoxicity 
[26], the natural killer activity of KC 127,281 could 
be related to the Kurloff CS-PG. The simultaneous 
presence in KB of acid phosphatases [3,29] and 
other acid hydrolases (Buat et al., unpublished) as 
observed in numerous other leukocytic granules 
[30-321 suggests that CS-PG are involved in en- 
zymatic storage [33]. Such findings would confirm 
the hypothesis of a lysosomal nature of the KB [3]. 
Mr 
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Fig.4. Effect of chondroitinase AC on the fluorographic 
pattern of purified Kurloff chondroitin [35S]sulphate 
proteoglycan. Lanes a and c correspond to the sulphated 
peak from DEAE-cellulose chromatography. Lane b, 
corresponding to the same sample after digestion, shows 
the complete absence of labelling. After PAGE-lo% 
SDS, the gels were silver stained, dried and exposed on 
Kodak X-Omat AR films for 30 days at -70°C. 
3200 dpm were deposited per lane. ikf, values indicated 
on the left were evaluated by the use of marker proteins. 
SG, stacking el; RG, resolving el. 
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